Management of Hepatitis B Vaccine Non-Responders

Definition and Identification of Non-Responders

A non-responder is defined as a person with inadequate response to vaccination (serum anti-HBs <10 mIU/mL) after completing a standard 3-dose hepatitis B vaccine series, according to the Centers for Disease Control and Prevention (CDC) 1, 2
Testing for anti-HBs should be performed 1-2 months after the final dose of vaccine to determine response status, as recommended by the CDC 2

The CDC recommends administering a single additional dose of hepatitis B vaccine as the first step for non-responders after initial 3-dose series 1, 2
Follow-up testing for anti-HBs should be performed 1-2 months after this additional dose, as recommended by the CDC 1
If still non-responsive, the CDC recommends completing a second full 3-dose series of hepatitis B vaccine 1, 2
Final testing for anti-HBs should be performed 1-2 months after completing the second series to document response status for future reference, as recommended by the CDC 1, 2

25-50% of non-responders develop protective antibody levels after a single additional dose, according to the CDC 3
44-100% develop protective antibody levels after a complete 3-dose revaccination series, as reported by the CDC 3
Persons with measurable but low (<10 mIU/mL) levels of anti-HBs after initial series have better response to revaccination, according to the CDC 3

The Advisory Committee on Immunization Practices (ACIP) does not recommend more than two complete vaccine series in non-responders 3
For non-responders after two complete series, the CDC recommends administering two doses of HBIG (Hepatitis B Immune Globulin) if exposed to HBV in the future 1, 4
The American Academy of Family Physicians recommends administering HBIG x1 and initiating revaccination, or administering HBIG x2 for known non-responders with occupational exposure to HBsAg-positive source 5, 6

Age >40 years is a risk factor for non-response, with only 75% of people age 60+ developing protective antibody levels, according to the CDC 8, 3
Obesity is a risk factor for non-response, as reported by the CDC 8
Smoking is a risk factor for non-response, according to the CDC 8
Genetic factors contribute to non-response to hepatitis B vaccination, as reported by the CDC 8, 3
Immunocompromising conditions are a risk factor for non-response, according to the CDC 8, 3

The CDC recommends distinguishing between true non-response and waning antibody levels, as those with previously adequate response may still have immune memory protection 1
Testing for anti-HBs should be performed using a method that allows detection of the protective concentration (≥10 mIU/mL), as recommended by the CDC 1
When HBIG is administered, anti-HBs testing should be delayed until HBIG is no longer detectable (approximately 6 months after administration), according to the CDC 1
Persons who do not respond to revaccination should be tested for HBsAg to rule out chronic HBV infection, as recommended by the CDC 2